Literature DB >> 9922379

CFTR is a conductance regulator as well as a chloride channel.

E M Schwiebert1, D J Benos, M E Egan, M J Stutts, W B Guggino.   

Abstract

CFTR Is a Conductance Regulator as well as a Chloride Channel. Physiol. Rev. 79, Suppl.: S145-S166, 1999. - Cystic fibrosis transmembrane conductance regulator (CFTR) is a member of the ATP-binding cassette (ABC) transporter gene family. Although CFTR has the structure of a transporter that transports substrates across the membrane in a nonconductive manner, CFTR also has the intrinsic ability to conduct Cl- at much higher rates, a function unique to CFTR among this family of ABC transporters. Because Cl- transport was shown to be lost in cystic fibrosis (CF) epithelia long before the cloning of the CF gene and CFTR, CFTR Cl- channel function was considered to be paramount. Another equally valid perspective of CFTR, however, derives from its membership in a family of transporters that transports a multitude of different substances from chemotherapeutic drugs, to amino acids, to glutathione conjugates, to small peptides in a nonconductive manner. Moreover, at least two members of this ABC transporter family (mdr-1, SUR) can regulate other ion channels in the membrane. More simply, ABC transporters can regulate somehow the function of other cellular proteins or cellular functions. This review focuses on a plethora of studies showing that CFTR also regulates other ion channel proteins. It is the hope of the authors that the reader will take with him or her the message that CFTR is a conductance regulator as well as a Cl- channel.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9922379     DOI: 10.1152/physrev.1999.79.1.S145

Source DB:  PubMed          Journal:  Physiol Rev        ISSN: 0031-9333            Impact factor:   37.312


  102 in total

Review 1.  Polycystic kidney disease: In danger of being X-rated?

Authors:  J J Grantham; J P Calvet
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

Review 2.  Functional domains within the degenerin/epithelial sodium channel (Deg/ENaC) superfamily of ion channels.

Authors:  D J Benos; B A Stanton
Journal:  J Physiol       Date:  1999-11-01       Impact factor: 5.182

3.  Alternative treatment for secretory diarrhea revealed in a new class of CFTR inhibitors.

Authors:  Qais Al-Awqati
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

4.  Pharmacogenomics of the cystic fibrosis transmembrane conductance regulator (CFTR) and the cystic fibrosis drug CPX using genome microarray analysis.

Authors:  M Srivastava; O Eidelman; H B Pollard
Journal:  Mol Med       Date:  1999-11       Impact factor: 6.354

5.  Plasma membrane CFTR regulates RANTES expression via its C-terminal PDZ-interacting motif.

Authors:  Kim Estell; Gavin Braunstein; Torry Tucker; Karoly Varga; James F Collawn; Lisa M Schwiebert
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

6.  The H-loop in the second nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator is required for efficient chloride channel closing.

Authors:  Monika Kloch; Michał Milewski; Ewa Nurowska; Beata Dworakowska; Garry R Cutting; Krzysztof Dołowy
Journal:  Cell Physiol Biochem       Date:  2010-01-12

7.  Altered ion transport by thyroid epithelia from CFTR(-/-) pigs suggests mechanisms for hypothyroidism in cystic fibrosis.

Authors:  Hui Li; Suhasini Ganta; Peying Fong
Journal:  Exp Physiol       Date:  2010-08-20       Impact factor: 2.969

Review 8.  CFTR and TNR-CFTR expression and function in the kidney.

Authors:  Jackson Souza-Menezes; Geórgia da Silva Feltran; Marcelo M Morales
Journal:  Biophys Rev       Date:  2014-05-07

Review 9.  CFTR structure and function: is there a role in the kidney?

Authors:  J Souza-Menezes; M M Morales
Journal:  Biophys Rev       Date:  2009-01-17

10.  CFTR fails to inhibit the epithelial sodium channel ENaC expressed in Xenopus laevis oocytes.

Authors:  G Nagel; P Barbry; H Chabot; E Brochiero; K Hartung; R Grygorczyk
Journal:  J Physiol       Date:  2005-03-03       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.